# Taro Pharmaceuticals Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768

> Inspection records and compliance data for Taro Pharmaceuticals Inc. in Brampton, None. Access full analysis and detailed observations.

---

## Details

- Name: Taro Pharmaceuticals Inc.
- FEI Number: 3002808384
- Canada Business Number: 826234262RC0001
- City: Brampton
- State: None
- Country Name: Canada
- Address Line 1: 130 East Dr
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [FDA Inspection 1312804 - Taro Pharmaceuticals Inc. - 2026-03-27](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/e59f5915-8816-41de-8678-f56559c43897) — source: FDA, date: March 27, 2026
- [FDA Inspection 1312804 - Taro Pharmaceuticals Inc. - 2026-03-27](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/f7aedf41-6b70-4664-bccc-0be298a7c401) — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2026
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #87313 - 2025-09-09](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/eabe6733-8176-4144-97b5-680babb8ff98) — source: Canada, date: September 9, 2025
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86076 - 2025-03-24](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/634332a3-8201-49ff-922f-7a08eaa6666d) — source: Canada, date: March 24, 2025
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86075 - 2025-03-24](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/6af34c71-a270-4ef1-8471-2d81c570db7b) — source: Canada, date: March 24, 2025
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86073 - 2025-03-24](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/0b9e9b34-d88a-4937-81d4-56feb10445fe) — source: Canada, date: March 24, 2025
- [FDA Inspection 1257703 - Taro Pharmaceuticals Inc. - 2024-09-20](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/d29183ba-0f33-4829-a258-2920145d20b0) — source: FDA, date: September 20, 2024
- [FDA Inspection 1257703 - Taro Pharmaceuticals Inc. - 2024-09-20](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/8f4b6451-c55b-4bbe-b5c6-e93a6f7ba75e) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2024
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #80957 - 2023-05-02](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/6b22344d-c3ae-4235-a939-59b2dd17483c) — source: Canada, date: May 2, 2023
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #80865 - 2023-05-02](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/c2f9f829-1e17-4488-bd59-2f3cb26c3812) — source: Canada, date: May 2, 2023
- [483 - Taro Pharmaceuticals Inc. - 2022-09-16](https://www.globalkeysolutions.net/records/483/taro-pharmaceuticals-inc/bb5cda45-9f89-42a6-9724-d0f098043f78) — source: FDA, date: September 16, 2022
- [FDA Inspection 1180887 - Taro Pharmaceuticals Inc. - 2022-09-16](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/5f06f6fb-7c0a-44ca-8fd5-6aad610d4a0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2022
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78187 - 2022-02-14](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/3098e23a-f098-418a-85fc-d9cdcad0b232) — source: Canada, date: February 14, 2022
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78186 - 2022-02-14](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/c3d9b4c2-8cf6-485d-a196-7feb1ebe02d6) — source: Canada, date: February 14, 2022
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78185 - 2022-02-14](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/ab4a3aa4-e9e2-4725-bc1a-e4bb946912f4) — source: Canada, date: February 14, 2022
- [FDA Inspection 1088553 - Taro Pharmaceuticals Inc. - 2019-05-03](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/6c8456ba-f9bc-45c1-aab9-d88bf456c31a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2019
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #71803 - 2019-03-11](https://www.globalkeysolutions.net/records/canada_inspection/taro-pharmaceuticals-inc/21b17cb9-6224-463a-961c-51c9a05bf36d) — source: Canada, date: March 11, 2019
- [FDA Inspection 984831 - Taro Pharmaceuticals Inc. - 2016-07-29](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/48a32949-7f77-49a7-b273-e98b9542286a) — classification: No Action Indicated (NAI), source: FDA, date: July 29, 2016
- [FDA Inspection 868155 - Taro Pharmaceuticals Inc. - 2014-02-28](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/0a06ea8a-9cc4-48b6-80d7-b7c578599334) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2014
- [FDA Inspection 715947 - Taro Pharmaceuticals Inc. - 2011-02-11](https://www.globalkeysolutions.net/records/fda_inspections/taro-pharmaceuticals-inc/1523a739-6ef7-45d9-8250-337c1ae2119b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2011

## Related Companies

- [Pharmascience Inc.](https://www.globalkeysolutions.net/companies/pharmascience-inc/2fa6f1e7-a980-4d37-b8d0-daf9e3a309c4)
- [Bausch Health Companies Inc.](https://www.globalkeysolutions.net/companies/bausch-health-companies-inc/3190f4ed-695e-491f-a57e-1ef128f7e2af)
- [Voyant Beauty, Inc.](https://www.globalkeysolutions.net/companies/voyant-beauty-inc/881e2944-36f2-4984-9ca9-319b61788b64)
- [Halo Pharmaceutical Canada Inc](https://www.globalkeysolutions.net/companies/halo-pharmaceutical-canada-inc/1f4cfadf-e895-4fd7-a813-959f505dd7ce)
- [Dominion Veterinary Laboratories Ltd.](https://www.globalkeysolutions.net/companies/dominion-veterinary-laboratories-ltd/26f80038-e4b5-4f44-a5aa-88164d0c105b)
- [Patheon Inc.](https://www.globalkeysolutions.net/companies/patheon-inc/5aa1b743-e01d-49ef-afca-c234bb7fa32b)
- [Church & Dwight Canada Corp.](https://www.globalkeysolutions.net/companies/church-dwight-canada-corp/cbcb0b61-bee8-4359-88e4-831475253c5b)
- [Baxter Corporation](https://www.globalkeysolutions.net/companies/baxter-corporation/ca56a675-623d-4cdd-9810-05ae4ba274e0)
- [Trillium Health Care Products Inc.](https://www.globalkeysolutions.net/companies/trillium-health-care-products-inc/e3791250-cb4e-4726-b84b-e9ad526a38c3)
- [ALBERTA VETERINARY LABORATORES LTD](https://www.globalkeysolutions.net/companies/alberta-veterinary-laboratores-ltd/52238896-339f-4478-8a49-cb84a4f84655)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)